ADC manufacturing
Product Description
Sterling Pharma Solutions
-
GB
-
2016On CPHI since
-
4Certificates
-
1000 - 4999Employees
Company types
Primary activities
Sterling Pharma Solutions
-
GB
-
2016On CPHI since
-
4Certificates
-
1000 - 4999Employees
Company types
Primary activities
More Products from Sterling Pharma Solutions (4)
-
Product ADC development
More than 30 years' experience in ADC development and specialist bioconjugation services. -
Product Chemistry Services
Sterling offers a range of early phase chemistry services to ensure quality, purity and efficacy at every stage in your small molecule project. These services include: Drug discovery A comprehensive service to increase the chance of success from the start. We provide close scientific collaboration and exp... -
Product Small molecule API development
At Sterling we have extensive API Development capabilities ranging from route scouting and design, through to process optimisation and full validation support, including quality by design (QbD). As a PDMO®, science is at the core of everything that we do and underpins our approach to API Development, coupl... -
Product Small molecule API manufacturing
Scalable small molecule API manufacturing, from grams to tons: Our flexible and tailored approach to API manufacturing enables us to support even the most specialised and complex project requirements. Our facilities in the UK, EU and US are equipped with state-of-the-art API manufacturing equipment to supp...
Sterling Pharma Solutions resources (3)
-
News Sterling Pharma and MIB partner to develop low-cost route to new oral COVID drug
The new route uses a novel enzyme, cytidine aminotransferase, which would reduce the manufacturing cost of the drug -
News Sterling Pharma Solutions signs up to manufacture OncoTEX's ovarian cancer drug
The CDMO's expertise and capabilities a "perfect fit" for overcoming the challenges of manufacturing this complex molecule -
News Sterling Pharma seals acquisition of bioconjugation specialist ADC
By integrating its HPAPI capabilities with those at ADC Biotechnologies' Deeside facility, small molecule CDMO will be able to offer the development and manufacturing of toxin linkers
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance